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INTRODUCTION 39 40 The prokaryotic immune system, CRISPR/Cas9, has been successfully adopted for 41 genome editing in diverse species (Komor et al. 2017 ). An engineered, widely used 42 CRISPR/Cas9 system consists of two components: a single-molecule guide RNA 43 (gRNA) and the Cas9 DNA endonuclease (Jinek et al. 2012; Hwang et al. 2013 ). The 44 gRNA binds with Cas9 and directs Cas9 to produce double-strand DNA breaks in 45 specific DNA sequences determined by base pairing between the gRNA and a 20bp 46 DNA target. The only additional requirement in the DNA is the presence of 47 protospacer adjacent motif (PAM, canonically NGG) immediately following the 20bp 48 target sequence. One can therefore utilize CRISPR/Cas9 to target almost any 49 genomic region with extremely high selectivity. The resultant DNA breaks are often 50 repaired by non-homologous end joining (Lieber 2010 ), leading to deletions or (less 51 frequently) insertions until the target sequence is lost. Notably, the likely indel 52 profiles can be largely predicted based on local DNA sequences (Allen et al. 2018) . 53
The simplicity, robustness and predictability of Cas9-induced indels have made 54 CRISPR as the most favored strategy for targeted gene disruption. Further, one can 55 try to edit the genome around the Cas9 cut site via homology directed repair (HDR) 56 of DNA breaks (San Filippo et al. 2008) . With HDR, one can replace endogenous 57 sequences with some designer sequences by supplying an exogenous template 58 carrying the desired DNA sequence flanked by homology arms. Such tailored 59 genome modifications are versatile but can be difficult if not impossible to achieve 60 even with the CRISPR technology (Horlbeck et al. 2016; Isaac et al. 2016) . 61 62 Gene targeting is context-dependent and offers little flexibility in the design. Some 63 gene-targeting experiments are intrinsically more challenging than others. For 64 instance, certain manipulations strive for deletion of a sizable defined DNA fragment 65 or insertion of a long DNA sequence at a specific nucleotide position. This can be 66 extremely challenging if suitable gRNA sites are not available. Moreover, it can be 67 difficult to obtain and insert long homology arms into an already lengthy donor 68 DNA. In addition, the engineered gene products (made through correct gene 69 targeting) may unexpectedly compromise organism viability even in heterozygous 70 conditions. To recover rare gene-targeting events in those challenging cases 71 requires (1) generation of numerous offspring, each with independent trials, and (2) 72 enrichment of offspring with correct gene targeting (especially those with decreased 73 viability) by selection against 'unperturbed' progeny. 74 75 Golic+ is a transgene-based gene targeting system designed to achieve the above 76 two objectives (Chen et al. 2015) . First, it employs a bam promoter to confine gene 77 targeting to germ cells rather than germline stem cells (Chen and McKearin 2003; 78 Lehmann 2012). This theoretically guarantees independent gene targeting events in 79 individual offspring. Second, it carries two conditional toxic genes: one to eliminate 80 offspring that did not incorporate the donor DNA and the other to select against the 81 incorporation of donor DNA in off-target sites. These lethality-based selections 82 should therefore allow only offspring with correct gene targeting to survive into 83 adults. We envisioned that a low probability gene-targeting event would occur 84 eventually, and that assuming no recovery of false positives in Golic+, patience and 85 simple fly pushing would be all that is needed to ensure success. The induction of 86 gene targeting in germ cells further eliminates the need for single-founder crosses, a 87 practice to avoid recovery of clonally identical lines. The amount of fly pushing can 88 therefore be greatly reduced. Thus, for complex editing of genes in their native 89 environment, Golic+ is particularly affordable compared to embryo injections. 90 91 Nonetheless, since its debut in 2015, the original Golic+ failed to succeed at all gene-92 targeting experiments. We suspended several trials due to the inability to recover 93 correct gene targeting events after proving many candidates as false positives. In 94 this study, we deliver an enhanced Golic+ (E-Golic+) with (1) much more stringent 95 lethality selections plus (2) superior gene targeting efficiency. Strikingly, the E-96 Golic+ acts much more potently in male than female germ cells. From male founders, 97 we easily achieve a 100% success-rate with previously failed gene-targeting 98 experiments. Only in the most challenging case did we detect any false positives. In 99 this case, offspring with off-target integration were outnumbered two-fold by 100 offspring with correct gene targeting. Therefore, for extremely intractable or large-101 scale gene targeting experiments, one can perform group crosses to drastically 102 reduce the labor required for making numerous independent trials with minimal 103 false-positive contamination. In conclusion, E-Golic+ guarantees successful gene 104 targeting in Drosophila. Given the dependence of all key enzymes on the bam promoter, we first wondered if 134 the strength of bamP(198) is a key limiting factor in the performance of Golic+. We 135 addressed this issue by trying bamP(898), a longer and presumably stronger bam 136 promoter (Chen and McKearin 2003) . Notably, co-induction of Cas9, FLP, and I-SceI 137 by bamP(898) yielded many more survivors including false positives at even higher 138 ratios ( Supplemental Table) . The predominance of false positives overshadowed the 139 evidently more potent bamP(898). To improve the efficiency of Golic+ we need to 140 further identify and eliminate the source(s) of false positives. 141
142
We detected two categories of false positives. The first group consisted of escapers, 143 those without donor DNA incorporation. Errors in the donor DNA liberation step 144 resulted in defective reconstitution of the repressible toxicity gene ( Fig. 1A) . 145
Without a functional repressible toxic module, organism viability was no longer 146 coupled to genome incorporation of the donor DNA. To eliminate these escapers, we 147 need to ensure presence of an intact, repressible toxic gene ideally at the same 148 homologous site as the pre-integrated donor DNA. We met this requirement by 149 making and placing the 3xP3-RFP-marked 3XLexAop2-riTS-Rac V12 transgene at the 150 same attP sites used for holding donor DNAs ( or extrapolated from data in Table 2 . 214 215 targeting events in one of the three genes we tested. These results substantiate the 216 success in eliminating false positives with the newly introduced transgenes plus use 217 of circular templates instead. However, two of the three repeated trials remained 218 unsuccessful, demanding larger scales of fly pushing or higher gene targeting 219 efficiencies. 220 Using male founders, we readily recovered numerous correct gene-targeting 233 offspring from each of the three gene-targeting trials ( Table 2) . None of these trials 234 were successful with Golic+, and only one was successful with E-Golic+ using female 235 founders. To make vnd:T2A:KD, we recovered 73 offspring with vnd:T2A:KD from a 236 total of 200 male founders, as opposed to only 17 from a total of 300 female 237 founders. In the engineering of Nkx6:T2A:DBD, we utilized two gRNA choices and 238 
300 6 3 0 obtained 37 offspring with Nkx6:T2A:DBD from a total of 175 male founders, but 249 recovered none from a total of 185 female founders. In the third case, we aimed to 250 insert Gal4 into Gad1, which encodes an enzyme characteristic of GABAergic 251 neurons, to make Gad1:T2A:Gal4. Expressing GAL4 continuously in all GABAergic 252 neurons could be harmful. In fact, an earlier study has reported challenges in 253 maintaining an analogous fly stock generated through recombinase-mediated 254 cassette exchange (Diao et al. 2015) . Given the known challenges, we screened 255 through progeny from 300 male founders and recovered six offspring with 256 Gad1:T2A:Gal4. We validated the lines carrying Gad1:T2A:Gal4 by genomic PCR, and 257 further corroborated their Gal4 expression patterns highlighting GABAergic 258 neurons in adult brains co-stained with anti-GABA antibody (Fig. 4) . As expected, we 259 found that Gad1:T2A:Gal4 labeled several prominent groups of GABAergic neurons 260 reported previously (Okada et al. 2009 ). We observed prominent labeling of R 261 neurons that innervate the ellipsoid body ( Fig. 4A1 ), neurons dorsal, ventral, and 262 lateral to the antennal lobe neuropil (Fig. 4A2) , neurons on the surface of Medulla 263 (Fig. 4A3) , and neurons at the interface between medulla and lobula plate in the 264 posterior brain (Fig. 4A4 ). In addition to six correct gene-targeting lines carrying 265 To examine the improvements made on E-Golic+, both Golic+ and E-Golic+ were 524 applied to create vnd-T2A-KD, Nkx6-T2A-DBD, and Gad1-T2A-Gal4 knock-ins. In the 525 last Gad1-T2A-Gal4 knock-in case, we only construct one {donor, gRNA} for 526 targeting. Female founders were used in both Golic+ and E-Golic+ to reveal the 527 benefits of adopting circular donor plus a 3xP3-RFP marked 3X-riTS-Rac1 V12 toxicity 528 module to avoid false positives. Additionally, for E-Golic+, male founders showed 529 higher targeting efficiency, which helped us overcome the difficulties of knocking in 530 DBD in Nkx6 and Gal4 in Gad1. 
